WST

West Pharmaceutical Services, Inc.

HealthcareMedical - Instruments & SuppliesUSUSDPeers →

$328.03

+0.49%LiveJun 18, 2026

AI Brief

Market cap

$23.17B

52w range

206.80 – 336.82

P / E

—

EPS · FY 2025

$6.80

Volume

587.82K

Revenue · FY 2025

$3.07B

+6.26% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on West Pharmaceutical Services, Inc.’s valuation

decile 6 · 0% factors bull

News pulse · 14d

0 stories—All news →

No recent stories.

today

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$327.95

Change

+51.34%

Period high

$334.66

Period low

$210.08

Period start

$216.702025-06-23

Through 2026-06-18

Fair value

Football field →

Weighted blend

$135.14

-58.80% vs spot

Recommendation

Sell

18 of 19 methods

Method spread

0bull18bear

±5% threshold

Analyst PT consensus: $315.83 (-3.72%)

Candlestick · 1Y

Open in chart workstation →

WST

327.95+51.34%

H 336.82L 206.80MA50 304.96MA200 271.65Avg vol 797K

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+1.37%	-0.60%	+3.76%	+38.39%	+20.36%	+19.22%	+51.38%	-11.08%	-8.27%	+339.48%	+29452.25%

Insider · 30d

History →

Bought

0 txns

Sold

$17.59M

10 txns

Net flow

−$17.59M

Aftermarket

Live

Jun 18, 10:06 PM

Last trade

$334.50

Bid

$320.37

9 sh

Ask

$339.99

3 sh

Spread

$19.620

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$844.9M	$138.8M	$1.92
Q4 Dec 2025	$805M	$132.1M	$1.82
Q3 Sep 2025	$804.3M	$140M	$1.93
Q2 Jun 2025	$766.2M	$131.8M	$1.82
Q1 Mar 2025	$698.2M	$89.8M	$1.23
Q4 Dec 2024	$748.5M	$130.1M	$1.78

Sector & industry today

Live

Sectors

Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Technology
-0.95%
Healthcare
-1.51%
Consumer Defensive
-1.52%
Real Estate
-2.19%

Top industries (issuer's industry highlighted)

Medical - Instruments & Supplies
-1.83%
Oil & Gas Energy
+8.53%
Auto - Dealerships
-6.22%
Business Equipment & Supplies
+5.82%
Advertising Agencies
-5.20%
Grocery Stores
-4.35%
Financial - Mortgages
+4.08%
Broadcasting
+4.00%
REIT - Office
-3.71%
Computer Hardware
-3.67%
Other Precious Metals
-3.55%
REIT - Diversified
-3.43%

Analyst view

DB · price_targets + analyst_grades

Consensus target

$315.83

-3.72% upside

Low

$295.00

Median

$315.00

High

$340.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent analyst activity

3 latest

Jun 09, 2026GradeOverweightBarclays upgrades West Pharmaceutical on 'material' upside to estimatesBarclays
Jun 09, 2026PT$400.00Barclays upgrades West Pharmaceutical on 'material' upside to estimatesBarclays
Jun 01, 2026GradeOutperformWest Pharmaceutical assumed at Outperform from Peer Perform at Wolfe ResearchWolfe Research

Peers

Total assets

$4.27B

Total debt

$416.7M

Cash & equiv

$791.3M

Operating CF

$754.8M

Free cash flow

$468.9M

Buybacks

-$134M

Recent insiders

All →

Insider	Action	Shares	Value	Date
Winters Chad officer: VP, Chief Accounting Officer	Sell	896	$269.4K	Apr 27, 2026
Favorite Annette F officer: Sr. VP & Chief HR Officer	Sell	2,817	$859.75K	Apr 27, 2026
Witherspoon Charles officer: VP & Treasurer	Sell	225	$69.84K	Oct 29, 2024
Witherspoon Charles officer: VP & Treasurer	Sell	478	$148.37K	Oct 29, 2024
Witherspoon Charles officer: VP & Treasurer	Sell	500	$150K	Aug 19, 2024
Witherspoon Charles officer: VP & Treasurer	Sell	529	$158.7K	Aug 19, 2024

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$3.07B	$617.4M	$493.7M	$6.80	+16.06%
FY 2024	$2.89B	$594.6M	$492.7M	$6.69	+17.03%
FY 2023	$2.95B	$710.9M	$593.4M	$7.88	+20.11%
FY 2022	$2.89B	$763.5M	$585.9M	$7.73	+20.30%
FY 2021	$2.83B	$758.7M	$661.8M	$8.67	+23.38%